Imedra Healthcare was incorporated in 2017 as a healthcare company that markets and distributes a range of state-of-the-art healthcare products to improve the quality of life of our people. In Sri Lanka, we were the first to launch the first generic of Empagliflozin (to treat type 2 diabetes) under the brand of ‘Empa’ which has become the most trusted and prescribed brand in the market in 2019. Our company is also the first to introduce Microwave Tumour Ablation procedure which has helped patients fight cancer since 2017. The success of our organisation is based on building valuable and competent relationships throughout the industry. As such, our distribution chain exceeds 2500 outlets including chemists, modern trade, medical institutions and the state pharmaceutical corporation. In addition, we collaborate with the Ministry of Health in Sri Lanka to achieve our common goal of supporting a healthier society. Our patient-centered approach to provide a responsible service motivates us to do more every day and we are ever-proud of our skilled and dedicated staff that work towards achieving this goal. Vision: To be the most trusted, ethical and quality healthcare products provider in Sri Lanka Mission: To facilitate world-class technology in healthcare to support a healthier society